CONCORD HC GP News

CONCORD HC GP: Annual Report 2024

HKEXApr 25 08:00 ET · Announcements

Here's Why Concord Healthcare Group (HKG:2453) Can Afford Some Debt

Simply Wall StMar 31 20:53 ET

Meizhong Jiahe (02453) reported its annual performance, with a net loss attributable to shareholders of 0.443 billion yuan, an increase of 18.8% year-on-year.

Meizhong Jiahe (02453) announced its annual performance results for the year ending December 31, 2024, with the group achieving revenue of RMB...

Zhitong FinanceMar 27 11:23 ET

Express News | Concord Healthcare - Revenue for Year RMB388.3 Mln

ReutersMar 27 10:55 ET

Express News | Concord Healthcare Group Co Ltd - FY Adjusted Net Loss RMB443.9 Mln

ReutersMar 27 10:55 ET

CONCORD HC GP: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2024

HKEXMar 27 10:54 ET · Announcements

Meizhong Jiahe (02453.HK) will hold a Board of Directors meeting on March 27 to approve the annual performance.

Glory Holdings announced on March 17 that Meizhong Jiahe (02453.HK) will hold a Board of Directors meeting on March 27, 2025, to approve the annual performance announcement of the company and its subsidiaries for the financial year ending December 31, 2024, as well as to consider the proposal to distribute a final dividend (if any).

Gelonghui FinanceMar 17 06:40 ET

Meizhong Jiahe [02453] is currently reported at 8.14 Hong Kong dollars, with an increase of 10.30%.

As of 10:38, Meizhong Jiahe [02453] reported 8.14 Hong Kong dollars, up 0.76 Hong Kong dollars or 10.30% from yesterday's closing price of 7.38 Hong Kong dollars, with a transaction volume of 3.4884 million Hong Kong dollars. Today's highest price is 8.14 Hong Kong dollars, the lowest price is 7.16 Hong Kong dollars. Based on yesterday's closing price, the 10-day average price is 7.94 Hong Kong dollars, the 50-day average price is 12.78 Hong Kong dollars, and the current PE is -11.93 times, with a 14-day strength index of 26.37.

Jingwu Financial NewsJan 21 21:38 ET

Meizhong Jiahhe (02453.HK) suggests adopting the Listed in Hong Kong incentive plan.

Gelonghui announced on January 3 that Meizhong Jiahe (02453.HK) has resolved on January 3, 2025, to propose the adoption of the company's incentive plan for shares Listed in Hong Kong. The incentive plan will take effect after being reviewed and approved by the company's shareholders at the upcoming extraordinary general meeting. The incentive plan aims to (i) promote the company's long-term sustainable development and achievement of performance goals; (ii) closely align the interests of the incentivized parties with those of shareholders, investors, and the company to enhance corporate cohesion and maximize corporate value; and (iii) improve the company's incentive mechanism to attract, motivate, and retain those who are continuously committed to the company.

Gelonghui FinanceJan 3 08:04 ET

Concord Healthcare Group to Consult With Private American Academic Medical Center for Medical, Administrative Effectiveness

MT NewswiresJan 3 07:00 ET

Hong Kong stock movement | Meizhong Jiahe (02453) rose over 5% during trading after signing a cooperation agreement with Mayo Clinic.

Meizhong Jiahe (02453) rose more than 5% during trading. As of the time of publication, it increased by 4.44%, priced at 13.16 Hong Kong dollars, with a trading volume of 23.7271 million Hong Kong dollars.

Zhitong FinanceJan 2 20:46 ET

Meizhong Jiahe (02453.HK): Mayo Clinic International plans to provide the group with advisory services regarding organizational goals and clinical practices.

Gelonghui, January 2 | Meizhong Jiahe (02453.HK) announced that recently, the company has entered into a cooperation agreement with the Mayo Foundation for Medical Education and Research. According to this agreement, Mayo Clinic International agrees to provide consultation services regarding organizational goals and clinical practices to the group. The agreement is valid for three (3) years. The Board of Directors emphasizes that the implementation of the cooperation establishes a foundation for long-term collaboration between both parties, and this cooperation must be formalized after a clear scope of work is signed.

Gelonghui FinanceJan 2 09:04 ET

[Hong Kong Stock Connect] Meizhong Jiahe (02453) surged nearly 30%, previously triggering the market adjustment mechanism. The company is expected to benefit from the new medical insurance policy in Guangzhou.

Jingu Financial News | Meizhong Jiahe (02453) stock price soared, triggering the market adjustment mechanism and entering a cooling-off period; as of the time of this report, it has increased by 29.45%, priced at 14.24 Hong Kong dollars, with a transaction volume of 16.861 million Hong Kong dollars. In terms of news, recently, the Guangzhou Medical Insurance Bureau and ten other departments jointly issued the "Notification on Several Measures for Building an Open Multilayer Medical Insurance System in Guangzhou" (hereinafter referred to as the "Notification"). This new policy focuses on three dimensions, with a total of seventeen measures, aimed at supporting the effective connection and supplementation of commercial health Insurance and the basic medical security system, promoting the innovative design of commercial health Insurance products, and opening up.

Jinwu Financial NewsJan 1 21:11 ET

Express News | Concord Healthcare - Zgc Tech Leasing to Provide Finance Lease Service to Co by Sale & Leaseback of Medical Equipment for RMB200 Mln

ReutersDec 17, 2024 17:05 ET

Meizhong Jiahe (02453.HK): Proton therapy equipment medical instruments registration application has been approved.

On December 9th, Meizhong Jiahe (02453.HK) announced that Guangzhou Taihe Cancer Hospital Co., Ltd. (operated under the name of Guangzhou Taihe Cancer Hospital, in which the company owns 80% equity) has purchased a customized proton therapy equipment and started clinical trials with this equipment. The company submitted a large medical equipment configuration license application for the proton therapy equipment to the National Health Commission of China on April 29, 2024, and the application was approved by the National Health Commission on September 13, 2024.

Gelonghui FinanceDec 8, 2024 18:59 ET

Express News | Concord Healthcare - Approval on Application for Registration Certificate for Medical Device for Proton Therapy Equipment

ReutersDec 8, 2024 18:56 ET

Would Concord Healthcare Group (HKG:2453) Be Better Off With Less Debt?

Simply Wall StDec 3, 2024 19:06 ET

Concord Healthcare Group Posts 6% Decline in H1 Loss

MT NewswiresOct 29, 2024 05:11 ET

CONCORD HC GP: SUPPLEMENTAL ANNOUNCEMENT TO INTERIM RESULTSANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024AND INTERIM REPORT 2024

HKEXOct 28, 2024 10:05 ET · Announcements

Meinian Health [02453] is now trading at 21.3 Hong Kong dollars, with a gain of 11.52%.

As of 09:37, Meixin Jiahe [02453] reported a price of 21.3 Hong Kong dollars, up 2.2 Hong Kong dollars or 11.52% from the previous closing price of 19.1 Hong Kong dollars. The turnover is 23.7774 million Hong Kong dollars, with today's highest price at 21.3 Hong Kong dollars and the lowest price at 18.12 Hong Kong dollars. Based on the previous day's closing price, the 10-day average price is 14.85 Hong Kong dollars, and the 50-day average price is 22.24 Hong Kong dollars. The current PE ratio is -30.88 times, and the 14-day relative strength index is 63.16.

Golden Guard Financial NewsOct 24, 2024 21:37 ET